2004 Annual Meeting | Diagnosis and Management of Acute Myelopathies

Date Friday 04/30/04

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) Douglas A. Kerr, MD, PhD

Topic(s) Spinal Cord/Nerve Root Disorders/Neurorehabilitation

Learning Objectives Upon completion:
Participants should be able to recognize the symptoms of acute myelopathies and institute an appropriate work up; classify acute myelopathies into compressive vs. non-compressive, inflammatory vs. non-inflammatory and monofocal vs. multifocal; recognize systemic inflammatory disorders (i.e., systemic lupus erythematosis, sarcoidosis, Sjogren's syndrome) that may be present with ATM; recognize that ATM may be part of a multi-focal CNS inflammatory disorder (i.e., multiple sclerosis, neuromyelitis optica); recognize proposed immunopathogenic mechanisms that cause ATM; and understand the evidence that supports various treatment options in patients presenting with ATM.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:30 PM - 07:00 PM		Acute Transverse Myelitis: Diagnosis and Classification Douglas A. Kerr, MD, PhD
07:00 PM - 07:30 PM		Spinal MS Peter A. Calabresi, MD, FAAN
07:30 PM - 08:00 PM		Myelopathies Associated with Systemic Disease Thomas F. Scott, MD
08:00 PM - 08:30 PM		Non-inflammatory Myelopathies Douglas A. Kerr, MD, PhD
08:30 PM - 09:30 PM		Case Presentations and Discussion

Faculty Disclosures
Douglas A. Kerr, MD, PhD	Dr. Kerr has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Kerr has received personal compensation for serving as an employee of Generation Bio. Dr. Kerr has received personal compensation for serving as an employee of Atlas Venture. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AAVantgarde Therrapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Trace Neuroscience. Dr. Kerr has stock in Dyne Therapeutics. Dr. Kerr has stock in Generation Bio.
	No disclosure on file
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.

��ɫ��

��ɫ��